DrugPatentWatch Database Preview
Details for Patent: 8,309,572
» See Plans and Pricing
Which drugs does patent 8,309,572 protect, and when does it expire?
Patent 8,309,572 protects ANORO ELLIPTA, INCRUSE ELLIPTA, and TRELEGY ELLIPTA, and is included in three NDAs.
This patent has sixty-one patent family members in thirty-six countries.
Summary for Patent: 8,309,572
Title: | Muscarinic acetylcholine receptor antagonists |
Abstract: | Muscarinic Acetylcholine Receptor Antagonists and methods of using them are provided. |
Inventor(s): | Laine; Dramane I. (King of Prussia, PA), Palovich; Michael R. (King of Prussia, PA), McCleland; Brent W. (King of Prussia, PA), Neipp; Christopher E. (King of Prussia, PA), Thomas; Sonia M. (King of Prussia, PA) |
Assignee: | Glaxo Group Limited (Greenford, Middlesex, GB) |
Application Number: | 13/401,890 |
Patent Claim Types: see list of patent claims | Use; Delivery; |
Drugs Protected by US Patent 8,309,572
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | ANORO ELLIPTA | umeclidinium bromide; vilanterol trifenatate | POWDER;INHALATION | 203975-001 | Dec 18, 2013 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||||
Glaxo Grp England | INCRUSE ELLIPTA | umeclidinium bromide | POWDER;INHALATION | 205382-001 | Apr 30, 2014 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||||
Glaxosmithkline | TRELEGY ELLIPTA | fluticasone furoate; umeclidinium bromide; vilanterol trifenatate | POWDER;INHALATION | 209482-001 | Sep 18, 2017 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||||
Glaxosmithkline | TRELEGY ELLIPTA | fluticasone furoate; umeclidinium bromide; vilanterol trifenatate | POWDER;INHALATION | 209482-002 | Sep 9, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,309,572
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
African Regional IP Organization (ARIPO) | 2213 | Start Trial | |||
Argentina | 050902 | Start Trial | |||
Australia | 2005237576 | Start Trial | |||
Brazil | PI0510170 | Start Trial | |||
Canada | 2564742 | Start Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |